Thursday October 6, 2022, 6 – 7 p.m. AEDT (ie Sydney, daylight savings)
Zoom link: https://unimelb.zoom.us/j/86074935809

Prof. Gerald Watts: RNA therapeutics that target Lp(a) and TRLS

Professor Gerald Watts trained at Imperial & King’s College, London University, and was a scholar at Wolfson College, Oxford University. He is senior consultant physician, specializing in the rapidly developing field of cardio-metabolic medicine, and the current chair of the Familial Hypercholesterolemia Australasia Network. He leads the Cardio-metabolic Service in the Departments of Cardiology and Internal Medicine at Royal Perth Hospital and is Winthrop Professor of Cardio-metabolic Medicine in the University of Western Australia. Research interests include fundamental and applied aspects of lipid disorders and cardiovascular prevention, and improving healthcare delivery for patients with high risk dyslipidemias, such as familial hypercholesterolemia and hyperchylomicronemia.
He has supervised several Masters and PhD students and post-doctoral research fellows, and holds several research grants, with multiple international collaborations. Prof Watts has published over 750 articles and other works and is a highly cited author. He is on the editorial board of several journals, including Atherosclerosis, Metabolism, Annals of Medicine, Journal of Clinical Lipidology, American Journal of Preventative Cardiology, Current Opinion in Lipidology, and Current Opinion in Endocrinology and Diabetes.Supported by our Atherosclerosis Education Program Partners

October 04 2022